UBS adjusted its price target on United Therapeutics on June 30, 2025.
1 report, 0 independent
Updated Jun 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
UBS adjusted its price target on United Therapeutics on June 30, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
UBS
Swiss multinational investment bank and financial services company
-
United Therapeutics
biotech company based in Silver Spring, Maryland, United States
Related events
- UBS and Morgan Stanley downgraded Chemours price targets, while TSS sold Opteon refrigerants.
- UBS raised its price target after discussing demand trends with ServiceNow partners.
- Citigroup and UBS raised their price targets for Procter & Gamble.
- UBS raised its price target for Micron Technology.
- UBS analysts focused on Costco's membership growth while Bank of America trimmed its price target due to a cautious view.
Coverage
Newest first; wire copies grouped- Unknown outlet